Elevai Labs, Inc. (NASDAQ:ELAB – Get Free Report) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 54,800 shares, a growth of 66.1% from the March 31st total of 33,000 shares. Based on an average daily trading volume, of 662,400 shares, the short-interest ratio is presently 0.1 days.
Elevai Labs Stock Performance
Elevai Labs stock opened at $0.66 on Friday. Elevai Labs has a 52 week low of $0.57 and a 52 week high of $4.24. The stock has a 50-day simple moving average of $0.69.
Elevai Labs (NASDAQ:ELAB – Get Free Report) last released its quarterly earnings data on Friday, March 29th. The company reported ($0.08) EPS for the quarter. The company had revenue of $0.70 million for the quarter.
Elevai Labs Company Profile
Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.
See Also
- Five stocks we like better than Elevai Labs
- Insider Trading – What You Need to Know
- 3 Stocks Leading the U.S. Agriculture Comeback
- What is Insider Trading? What You Can Learn from Insider Trading
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Investing in Travel Stocks Benefits
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Elevai Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevai Labs and related companies with MarketBeat.com's FREE daily email newsletter.
